News

You may have heard about Ozempic, a medicine for type 2 diabetes approved by the FDA in 2017. This medicine is for use with diet and exercise to improve control of blood glucose levels in people ...
Medicamentos populares para bajar de peso como Ozempic y Wegovy han sido añadidos a la lista de fármacos de Medicare que serán ... El medicamento inyectable Ozempic, el 1 de julio de 2023, en ...
There are serious GI side effects of Ozempic, including nausea, diarrhea, and more. Learn what this drug does to your body and how to manage side effects.
One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks ...
What’s the difference between Ozempic, Wegovy, other weight loss drugs? by Taylor Delandro - 05/07/25 7:07 AM ET. by Taylor Delandro - 05/07/25 7:07 AM ET.
Researchers have been testing Ozempic's superpowers on chronic diseases beyond diabetes and obesity, such as colorectal cancer, osteoarthritis, drug and alcohol addiction and brain disorders.
Ozempic and other game-changing weight loss drugs are popular for a reason — but, nutrition experts say, don't forget the simple foods that were out there controlling appetites first.
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show the medications for Type 2 diabetes and weight loss can decrease the ...
A recent study linked GLP-1 (glucagon-like peptide-1) agonists — the class of drugs that includes semaglutides — to an increased risk of hair loss. Here's what you should know.
A new study adds to mounting evidence showing that drugs like Ozempic don’t just treat diabetes — they can also prevent it. The new paper, published Wednesday in The New England Journal of ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday. CNN values your feedback 1.
Should Ozempic be added to the water supply? That is the kind of half-joking question that doctors kick around when a new class of drugs begins to help a big chunk of the population.